Mindfulness-based stress reduction in patients with irritable bowel syndrome.
Alimentary Pharmacology & Therapeutics September 1, 2011
Mindfulness-based stress reduction in patients with irritable bowel syndrome.
Alimentary Pharmacology & Therapeutics
ISSN 0269-2813, 1365-2036
4 papers in the library · 197 citations · publishing 1999-2011
Papers
Mindfulness-based stress reduction in patients with irritable bowel syndrome: authors’ reply
Alimentary Pharmacology & Therapeutics August 2, 2011 David J. Kearney, Tracy L. Simpson
Sirs, We would like to thank Drs Asarel and Simren for their comments regarding our work.1 We certainly agree that studies of mindfulness interventions for irritable bowel syndrome (IBS) are of potentially great clinical importance. Given the high prevalence of multiple overlapping somatic syndromes,2 psychiatric conditions3 and trauma among IBS patients, interventions that emphasise learning...
Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom‐specific anxiety and quality of life
Alimentary Pharmacology & Therapeutics June 9, 2011 David J. Kearney, Kelly McDermott, Michelle E. Martinez et al. 63 citations
BACKGROUND: Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. AIM: To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life. METHODS: This is a...
Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications
Alimentary Pharmacology & Therapeutics February 1, 1999 Jones, Simpson 134 citations
The social use of ecstasy (methylenedioxymethampheta‐mine, MDMA) and amphetamines is widespread in the UK and Europe, and they are popularly considered as ‘safe’. However, deaths have occurred and hepatotox‐icity has featured in many cases of intoxication with amphetamine or its methylenedioxy analogues such as ecstasy. Recreational use of these drugs presents an important but often concealed...
DOI: 10.1046/j.1365-2036.1999.00454.x (opens in new tab)
Ecstasy
MDMA
Amphetamine
Hallucinogen
+2